0001209191-15-059095.txt : 20150702
0001209191-15-059095.hdr.sgml : 20150702
20150702180939
ACCESSION NUMBER: 0001209191-15-059095
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150630
FILED AS OF DATE: 20150702
DATE AS OF CHANGE: 20150702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001178711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330960223
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 KNEELAND STREET
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02111
BUSINESS PHONE: (617) 275-0040
MAIL ADDRESS:
STREET 1: 75 KNEELAND STREET
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02111
FORMER COMPANY:
FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc
DATE OF NAME CHANGE: 20090130
FORMER COMPANY:
FORMER CONFORMED NAME: NOVACEA INC
DATE OF NAME CHANGE: 20020724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haskel William M.
CENTRAL INDEX KEY: 0001524372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36066
FILM NUMBER: 15971391
MAIL ADDRESS:
STREET 1: ONE MEADOWLANDS PLAZA
CITY: EAST RUTHERFORD
STATE: NJ
ZIP: 07073
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-30
0
0001178711
Paratek Pharmaceuticals, Inc.
PRTK
0001524372
Haskel William M.
C/O PARATEK
75 KNEELAND STREET, 6TH FLOOR
BOSTON
MA
02111
0
1
0
0
Sr. VP, Sec. & General Counsel
Common Stock
2015-06-30
4
A
0
20000
0.00
A
21000
D
Stock Option (right to buy)
25.77
2015-06-30
4
A
0
130000
0.00
A
2025-06-29
Common Stock
130000
130000
D
The exercise price is equal to the closing sales price per share of Common Stock as reported on The Nasdaq Global Market on the date of grant.
The shares shall vest as follows: 32,500 shares (25%) shall vest on June 29, 2016; and the remaining 97,500 (75%) shares shall vest in monthly installments of 2,708 shares (1/36th) on a monthly basis thereafter.
/s/ William M. Haskel
2015-07-02